Pfizer GDF15 Monoclonal Antibody Ponsegromab Injection Applied for Clinical Application
On May 10, CDE's official website showed that Pfizer's clinical trial application for Ponsegromab injection was accepted. This is the first GDF15 monoclonal antibody to be declared for clinical application in China, which can be used for the treatment of cancer cachexia, solid tumors, anorexia, heart failure, etc.
Ponsegromab is currently mainly developed for the treatment of cancer cachexia (cancer cachexia). This is a secondary reaction characterized by systemic metabolic disorders mainly caused by tumor cell products and cytokines released by the body, manifested as loss of appetite, weight loss, anemia, weakness, and exhaustion. About 20% of cancer patients' deaths are related to cancer cachexia.
2026-10-05
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
How Can Investors Benefit from Pfizer's Dividend Yield for a Monthly Income?
-
Pfizer's Revenue Forecast Disappoints, Stock Plummets: A Closer Look at the Challenges Ahead
-
Pfizer's Angela Hwang Departs as Company Completes Seagen Acquisition and Establishes New Oncology Division
-
2023 Senior Management Personnel Changes of Multinational Pharmaceutical Companies in China, what's behind it? - III
-
Milestone Approvals in Sickle Cell Disease (SCD): FDA Approves Two Therapies before Pfizer's GBT601 Disclosure
-
Pfizer's Strategic Shift in China's Pneumococcal Vaccine Market
-
Pfizer Receives Conditional Approval for Tislelizumab in the Treatment of Relapsed or Refractory Extranodal NK/T-cell Lymphoma (ENKTL)
-
Pfizer: In 2023, COVID-19's product revenue will decline significantly
-
25 million with one injection?! The record for 'the world's most expensive drug' is still controversial...
-
Pfizer's paxlovid reduces the risk of COVID-19 by 26%
Recommend Reading
-
SABIC Agri-Nutrients Advances Mega Fertilizer Expansion With 1.2 Million MT/Year Ammonia Plant
-
South Korea Moves Urgently to Control Petrochemical Feedstock Hoarding as Supply Chain Risk Escalates to the National Security Level
-
Dow Chemical Weighs Exit from $20 Billion Chemical Joint Venture with Saudi Aramco
-
Wanhua Chemical Establishes a RMB 1.488 Billion New Energy Materials Company in Weifang, Further Integrating Green Power and Battery Materials Businesses
-
Kering and L'Oréal Form $4 Billion Strategic Alliance in Luxury Beauty and Wellness
-
Business Society’s Market Outlook for n-Butanol on August 17, 2026: Volatile with a Strongly Bullish and Consolidating Trend
-
Business Society’s August 17, 2026 Toluene Market Outlook: Volatile
-
Premium Global Chemical Sourcing Requests (23 - 27 Feb, 2026)
-
Business Society’s Market Outlook for Phthalic Anhydride on August 17, 2026: Continuing a Slight Rise
-
Business Society’s Market Outlook for Gasoline on August 17, 2026: Fluctuating Trend